Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

GSK snags Japanese approval for first hepatitis B functional cure, Hibsago | PharmaVoice

Pharma Tech

GSK snags Japanese approval for first hepatitis B functional cure, Hibsago

Aug 25, 2026, 10:35 AM

Read Full Article → GSK snags Japanese approval for first hepatitis B functional cure, Hibsago

GSK snags Japanese approval for first hepatitis B functional cure, Hibsago

Translate article text

Choose a language and wait for the translated text.

Analysts are heralding functional cures like Hibsago in chronic hepatitis B as the next frontier in treatment for patients.